JPT Peptide Technologies GmbH

Germany

https://www.jpt.com/

Excipients & Specialty Ingredients

Regulatory, Tech Transfer & Support Services

Company Overview

About

JPT Peptide Technologies GmbH is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Quality Control, Stability Testing, Method Development

Therapeutic Areas

Oncology

Hematology

Quick Facts

HQ:Germany

Founded:1994

Employees:1,099

Capabilities & Services

Core Capabilities

Oral Solid Dose
Solid Dose Manufacturing
Formulation Development

Technology Platforms

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Lyophilized (Freeze-Dried)

Sterile Injectable

Containment Capabilities

OEB 5 (≤1 µg/m³)

Cytotoxic / ADC Handling

Production Scales

Phase III Clinical Trials

Commercial Scale

Clinical

Markets Served

Asia-Pacific

Manufacturing Facilities

1 site worldwide

JPT Peptide Technologies GmbH - Germany Facility

Germany

View on Map

Site Capabilities

Quality Control

Stability Testing

Method Development

Regulatory Approvals

Drug Approval HTF3MX

Health Canada · #APR-GU57SKOW · 2021-03-01

View

Drug Approval 83W4RA

PMDA · #APR-SPNNTLE9 · 2019-05-01

View

Certifications

EMA GMP Certificate

European Medicines Agency

Cert #: CERT-UIUTBJ56

Issued: 2020-11-13

Expires: 2025-09-13

Download

ISO 9001:2015

International Organization for Standardization

Cert #: CERT-B4OHON3M

Issued: 2020-07-10

Expires: 2025-12-23

Download

ISO 13485:2016

International Organization for Standardization

Cert #: CERT-L531HC7D

Issued: 2020-07-02

Expires: 2025-08-23

Download

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-1V79DJIL

Issued: 2020-10-18

Expires: 2025-10-20

Download

Customer Reviews

4.3

Overall Rating

Project Management4.4

Technology Transfer4.5

On-Time Delivery3.7

Communication Responsiveness4.8

Innovation4.3

Company Documents

No documents available.

Loading CDMO intelligence...

Send Inquiry

Please log in to send an inquiry to this CDMO.